Automated Cell Culture System Market Growth Drivers and Challenges:
Growth Drivers
-
Significant Demand in the Treatment of Skin Problems - In 2022, over 6 million Americans were found to be living with psoriasis while about 200 million were across the globe.
The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.
- Rising Cases of Non-Communicable Diseases - Data published by the World Health Organization showed that nearly 41 million individuals die due to non-communicable diseases every year.
- Higher Prevalence of Infectious Diseases - The annual rate of death caused by infectious diseases is estimated to be more than 15 million a year.
- Growing Healthcare Expenditure Across the Globe - As per the statistics provided by the World Bank, global health expenditure was estimated to reach USD 1,121.9 per capita.
- Increasing Number of Clinical Trials - As of 2021, the number of clinical trials is estimated to be nearly 0.4 million in about 200 countries.
Challenges
-
Lack of Skilled Medical Professionals
-
Lack of Required Technology to Develop the Cell Culture System
- Requirement for Higher Initial Investment
Automated Cell Culture System Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
8.7% |
|
Base Year Market Size (2025) |
USD 16.58 Billion |
|
Forecast Year Market Size (2035) |
USD 38.18 Billion |
|
Regional Scope |
|
